Applied Therapeutics, Inc. (APLT)
NASDAQ: APLT · Real-Time Price · USD
9.43
+0.50 (5.60%)
Nov 20, 2024, 4:00 PM EST - Market closed
Applied Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for APLT stock have an average target of 12.5, with a low estimate of 11 and a high estimate of 14. The average target predicts an increase of 32.56% from the current stock price of 9.43.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 19, 2024.
Analyst Ratings
The average analyst rating for APLT stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $8 → $11 | Strong Buy | Maintains | $8 → $11 | +16.65% | Sep 19, 2024 |
| Leerink Partners | Leerink Partners | Buy Maintains $11 → $14 | Buy | Maintains | $11 → $14 | +48.46% | Sep 19, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | -15.16% | Aug 27, 2024 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jul 31, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $12 | Buy | Reiterates | $12 | +27.25% | Jul 17, 2024 |
Financial Forecast
Revenue This Year
1.84M
from 9.99M
Decreased by -81.62%
Revenue Next Year
60.05M
from 1.84M
Increased by 3,169.03%
EPS This Year
-0.97
from -1.42
EPS Next Year
-0.47
from -0.97
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.4M | 117.6M | 213.2M | ||
| Avg | 1.8M | 60.1M | 146.9M | ||
| Low | 294,000 | 11.6M | 50.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -55.7% | 6,302.3% | 255.0% | ||
| Avg | -81.6% | 3,169.0% | 144.6% | ||
| Low | -97.1% | 531.6% | -16.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.77 | -0.29 | 0.75 | ||
| Avg | -0.97 | -0.47 | 0.19 | ||
| Low | -1.19 | -0.61 | -0.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.